Skip to content
Open access · CC-BY via OpenAlex

Implications of the Gut Microbiome in Alzheimer’s Disease: A Narrative Review

Palvi Mroke, Raman Goit, Muhammad Rizwan, Saba Tariq, Abdul Wahid Rizwan, Muhammad Umer, Fariha F Nassar, Angela Juliet Torijano Sarria, Dilpreet Singh, Imran Baig

Cureus · 2024 · ▲ 7 citations

Abstract

Alzheimer's disease (AD) is a progressive neurodegenerative disorder, with its prevalence doubling approximately every decade. It is a significant contributor to disability-adjusted life-years in individuals aged 50 and older, impacting a substantial portion of this population globally. The pathophysiology of AD is primarily explained by two hypotheses: the amyloid cascade hypothesis and the tau hypothesis. While the amyloid cascade hypothesis is widely accepted as the main contributor to AD, both mechanisms promote neuroinflammation by driving the formation of amyloid-beta (Aβ) plaques and tau tangles, which are key features of the neurodegenerative process. Recent studies highlight the critical role of the gut microbiome (GMB) in the progression of AD. Gut dysbiosis has been linked to neuroinflammation, altered Aβ metabolism, blood-brain barrier disruption, and changes in neuroactive metabolites. Targeting the GMB offers potential therapeutic avenues aimed at restoring microbial balance and mitigating the effects of dysbiosis. The gut-brain axis, crucial for neurological health, remains underexplored in AD, especially since current research is limited to animal models and small human studies, leaving uncertainty about specific gut bacteria's roles in AD. Currently, pharmacological treatments for AD include cholinesterase inhibitors and memantine. This review discusses newer and emerging treatments targeting Aβ and tau pathology, alongside microbiome-based interventions. Larger, human-based studies with diverse populations are essential to establish the therapeutic efficacy of these microbiome-targeted treatments and their long-term impact on AD management.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.7759/cureus.73681
Canonical
link ↗
Fetched
2026-10-07 MST

Cite this

APA
Mroke, P., Goit, R., Rizwan, M., Tariq, S., Rizwan, A.W., Umer, M., Nassar, F.F., Sarria, A.J.T., Singh, D., &amp; Baig, I. (2024). Implications of the Gut Microbiome in Alzheimer’s Disease: A Narrative Review. <em>Cureus</em>. https://doi.org/10.7759/cureus.73681
Vancouver
Mroke P, Goit R, Rizwan M, Tariq S, Rizwan AW, Umer M, et al. Implications of the Gut Microbiome in Alzheimer’s Disease: A Narrative Review. Cureus. 2024. doi:10.7759/cureus.73681.
BibTeX
@article{palvi2024Implic, title = {Implications of the Gut Microbiome in Alzheimer’s Disease: A Narrative Review}, author = {Palvi Mroke and Raman Goit and Muhammad Rizwan and Saba Tariq and Abdul Wahid Rizwan and Muhammad Umer and Fariha F Nassar and Angela Juliet Torijano Sarria and Dilpreet Singh and Imran Baig}, journal = {Cureus}, year = {2024}, doi = {10.7759/cureus.73681}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings